All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
MRNA total return snapshot: MRNA returned +144.26% over the past year and +128.11% YTD, with dividends reinvested. Since Dec. 7, 2018, MRNA is up +261.67% in nominal total return, or +18.56%/yr, and is currently −86.11% below its total-return high on Aug. 9, 2021.
Data ending Fri Jun. 26, 2026
| Fri 2018-12-07💬 to Fri 2026-06-26 |
YTD
Return |
1 Year
Return |
||||
|---|---|---|---|---|---|---|
| MRNA × |
+128.11%
2026-06-26 |
+144.26%
2026-06-26 |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Fri 2018-12-07💬 to Fri 2026-06-26 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| MRNA × |
+261.67%
+18.56%/yr |
+4.21%/yr
(R2=0.010) |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Fri 2018-12-07💬 to Fri 2026-06-26 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| MRNA × |
$10,000.00
2018-12-07 |
$36,166.67
2026-06-26 |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Year | MRNA |
|---|---|
| 2026 (YTD) | +128.11% |
| 2025 | −29.08% |
| 2024 | −58.19% |
| 2023 | −44.63% |
| 2022 | −29.28% |
| 2021 | +143.11% |
| 2020 | +434.10% |
| 2019 | +28.09% |
| 2018 | −17.90% |
| Fri 2018-12-07💬 to Fri 2026-06-26 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| MRNA × |
−86.11%
from 2021-08-09 peak |
−95.38%
2025-11-20 from 2021-08-09 peak |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Period ending Fri 2026-06-26 |
1
Year |
2
Years |
3
Years |
5
Years |
10
Years |
|
|---|---|---|---|---|---|---|
| MRNA × | +144.26% |
−45.06% −25.88%/yr |
−44.13% −17.64%/yr |
−69.41% −21.10%/yr |
— | |
| Moderna Inc NASDAQ Common Stock | ||||||
